Skip to main content
Journal cover image

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.

Publication ,  Journal Article
Cavallari, LH; Beitelshees, AL; Blake, KV; Dressler, LG; Duarte, JD; Elsey, A; Eichmeyer, JN; Empey, PE; Franciosi, JP; Hicks, JK; Holmes, AM ...
Published in: Clin Transl Sci
May 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Transl Sci

DOI

EISSN

1752-8062

Publication Date

May 2017

Volume

10

Issue

3

Start / End Page

143 / 146

Location

United States

Related Subject Headings

  • United States
  • Risk Assessment
  • Practice Guidelines as Topic
  • Phenotype
  • Pharmacogenomic Variants
  • Pharmacogenetics
  • National Institutes of Health (U.S.)
  • Interdisciplinary Communication
  • Humans
  • Genotype
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cavallari, L. H., Beitelshees, A. L., Blake, K. V., Dressler, L. G., Duarte, J. D., Elsey, A., … Johnson, J. A. (2017). The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting. Clin Transl Sci, 10(3), 143–146. https://doi.org/10.1111/cts.12456
Cavallari, L. H., A. L. Beitelshees, K. V. Blake, L. G. Dressler, J. D. Duarte, A. Elsey, J. N. Eichmeyer, et al. “The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.Clin Transl Sci 10, no. 3 (May 2017): 143–46. https://doi.org/10.1111/cts.12456.
Cavallari LH, Beitelshees AL, Blake KV, Dressler LG, Duarte JD, Elsey A, et al. The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting. Clin Transl Sci. 2017 May;10(3):143–6.
Cavallari, L. H., et al. “The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting.Clin Transl Sci, vol. 10, no. 3, May 2017, pp. 143–46. Pubmed, doi:10.1111/cts.12456.
Cavallari LH, Beitelshees AL, Blake KV, Dressler LG, Duarte JD, Elsey A, Eichmeyer JN, Empey PE, Franciosi JP, Hicks JK, Holmes AM, Jeng L, Lee CR, Lima JJ, Limdi NA, Modlin J, Obeng AO, Petry N, Pratt VM, Skaar TC, Tuteja S, Voora D, Wagner M, Weitzel KW, Wilke RA, Peterson JF, Johnson JA. The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting. Clin Transl Sci. 2017 May;10(3):143–146.
Journal cover image

Published In

Clin Transl Sci

DOI

EISSN

1752-8062

Publication Date

May 2017

Volume

10

Issue

3

Start / End Page

143 / 146

Location

United States

Related Subject Headings

  • United States
  • Risk Assessment
  • Practice Guidelines as Topic
  • Phenotype
  • Pharmacogenomic Variants
  • Pharmacogenetics
  • National Institutes of Health (U.S.)
  • Interdisciplinary Communication
  • Humans
  • Genotype